Answers are grounded in this paper and cite their sources.
A total of 294 pooled samples from ten species were tested for the presence of Megalocytivirus pagrus 1 in a two-year survey. Among them, Megalocytivirus pagrus 1 was detected from 36 samples (pool prevalence of 12.24%) by PCR assay targeting the major capsid protein (MCP) gene. The MCP gene from five representative positives was sequenced. Pairwise identity and maximum-likelihood phylogenetic analyses based on MCP nucleotide sequences indicated close genetic relatedness between the five sequences obtained in this study and ISKNV Clade 1 reference sequences; four sequences exhibited ≥99.68% nucleotide identity to Clade 1 strains, whereas one displayed comparatively lower identity, but was still placed close to the ISKNV Clade 1-associated assemblage. These findings support the use of the MCP gene as a primary marker for distinguishing Megalocytivirus pagrus 1 genotype and clades; however, because the MCP gene constitutes less than 2% of the viral genome, additional loci (e.g., ATPase) or whole-genome sequencing are recommended for higher-resolution phylogenetic analysis. Taken together with additional metadata (host and reported origin), the MCP sequence provides a reference dataset for comparative analysis of Megalocytivirus pagrus 1 diversity. And as the findings here are based on gene sequence, it indicates genetic relatedness rather than a definite diagnosis of an infectious virus. The sequences are available in GenBank, and international cross-study comparison would support future scientific evaluation of the genus Megalocytivirus, in alignment with the World Organisation for Animal Health criteria.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: